All Stories

  1. A Critical Analysis of Sustainability Indicators for Education and Curricula in Higher Education Institutions and Their Adaptation to the Portuguese Context
  2. Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
  3. Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990–2021: a syst...
  4. Burden of disease scenarios for 204 countries
  5. Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
  6. Public health and health research data: Availability, needs and challenges
  7. Editorial: Public health and health research data: availability, needs and challenges
  8. Integration of sustainability in the curricula of public higher education institutions in Portugal: do strategic plans and self-report align?
  9. Engagement with the Community and Partnerships for Sustainable Food Production and Consumption in Portuguese Higher Education Institutions
  10. Editorial: Public Health Data Challenges of the COVID-19 pandemic: A Sisyphean task!
  11. Ageing and Long-Term Informal Care: The Reality of Two Countries in Europe: Denmark and Portugal
  12. Administrative databases as a tool for identifying healthcare demand and costs in an over-one million population
  13. Population-level risks of alcohol consumption by amount, geography, age, sex, and year: a systematic analysis for the Global Burden of Disease Study 2020
  14. Global, regional, and national burden of diseases and injuries for adults 70 years and older: systematic analysis for the Global Burden of Disease 2019 Study
  15. Impacts of COVID-19 and social isolation on academic staff and students at universities: a cross-sectional study
  16. Spatial, temporal, and demographic patterns in prevalence of smoking tobacco use and attributable disease burden in 204 countries and territories, 1990–2019: a systematic analysis from the Global Burden of Disease Study 2019
  17. Towards a common future: revising the evolution of university-based sustainability research literature
  18. COVID-19: the impact of a global crisis on sustainable development teaching
  19. Sustainability practices at private universities: a state-of-the-art assessment
  20. Five insights from the Global Burden of Disease Study 2019
  21. Global age-sex-specific fertility, mortality, healthy life expectancy (HALE), and population estimates in 204 countries and territories, 1950–2019: a comprehensive demographic analysis for the Global Burden of Disease Study 2019
  22. Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019
  23. Global burden of 87 risk factors in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019
  24. Measuring universal health coverage based on an index of effective coverage of health services in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019
  25. Mapping local patterns of childhood overweight and wasting in low- and middle-income countries between 2000 and 2017
  26. Universities speak up regarding the implementation of sustainable development challenges
  27. Sustainability Strategies in Portuguese Higher Education Institutions: Commitments and Practices from Internal Insights
  28. Department of Error
  29. Health effects of dietary risks in 195 countries, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017
  30. Experience of a Portuguese Center: Effectiveness of Direct-Acting Antiviral Therapy for Hepatitis C
  31. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of Disease Study 2017
  32. Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease ...
  33. Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017
  34. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017
  35. Measuring progress of the health-related Sustainable Development Goals for 195 countries
  36. Global, regional, and national age-sex-specific mortality and life expectancy, 1950–2017: a systematic analysis for the Global Burden of Disease Study 2017
  37. Population and fertility by age and sex for 195 countries and territories, 1950–2017: a systematic analysis for the Global Burden of Disease Study 2017
  38. Department of Error
  39. Education for sustainable development in Portuguese universities
  40. Measuring performance_Healthcare Access_Quality Index for 195 countries and territories
  41. Department of Error
  42. Measuring progress and projecting attainment on the basis of past trends of the health-related Sustainable Development Goals in 188 countries: an analysis from the Global Burden of Disease Study 2016
  43. Global, regional, and national age-sex specific mortality for 264 causes of death, 1980–2016: a systematic analysis for the Global Burden of Disease Study 2016
  44. Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
  45. Global, regional, and national disability-adjusted life-years (DALYs) for 333 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
  46. Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
  47. Department of Error
  48. The short-term effect of particulate matter on cardiorespiratory drug prescription, as a proxy of mild adverse events
  49. Healthcare Access and Quality Index based on mortality from causes amenable to personal health care in 195 countries and territories, 1990–2015: a novel analysis from the Global Burden of Disease Study 2015
  50. Evolution and patterns of global health financing 1995–2014: development assistance for health, and government, prepaid private, and out-of-pocket health spending in 184 countries
  51. Department of Error
  52. Global, Regional, and National Levels of Maternal Mortality, 1990–2015
  53. Education for Sustainable Development Through Policies and Strategies in the Public Portuguese Higher Education Institutions
  54. Department of Error
  55. Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015
  56. Global, regional, and national levels of maternal mortality, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015
  57. Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015
  58. Global, regional, national, and selected subnational levels of stillbirths, neonatal, infant, and under-5 mortality, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015
  59. Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015
  60. Global, regional, and national disability-adjusted life-years (DALYs) for 315 diseases and injuries and healthy life expectancy (HALE), 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015
  61. Measuring the health-related Sustainable Development Goals in 188 countries: a baseline analysis from the Global Burden of Disease Study 2015
  62. Correction to Lancet HIV 2016; 3: e361–87
  63. Estimates of global, regional, and national incidence, prevalence, and mortality of HIV, 1980–2015: the Global Burden of Disease Study 2015
  64. Amplitude Spectrum Area to Guide Defibrillation
  65. Cardiorespiratory treatments as modifiers of the relationship between particulate matter and health: A case-only analysis on hospitalized patients in Italy
  66. Using real-world healthcare data for pharmacovigilance signal detection – the experience of the EU-ADR project
  67. Burden of Diabetes Mellitus Estimated with a Longitudinal Population-Based Study Using Administrative Databases
  68. Gamifying requirement elicitation: Practical implications and outcomes in improving stakeholders collaboration
  69. Alveolar pentraxin 3 as an early marker of microbiologically confirmed pneumonia: a threshold-finding prospective observational study
  70. The Clinical and Economic Impact of Exacerbations of Chronic Obstructive Pulmonary Disease: A Cohort of Hospitalized Patients
  71. Epidemiological surveillance of colonising group B Streptococcus epidemiology in the Lisbon and Tagus Valley regions, Portugal (2005 to 2012): emergence of a new epidemic type IV/clonal complex 17 clone
  72. Harmonization process for the identification of medical events in eight European healthcare databases: the experience from the EU-ADR project
  73. The effect of revascularization procedures on myocardial infarction incidence rates and time trends: The MONICA-Brianza and CAMUNI MI registries in Northern Italy
  74. Collaborative Requirements Elicitation with Visualization Techniques
  75. iThink: A Game-Based Approach Towards Improving Collaboration and Participation in Requirement Elicitation
  76. Burden of acute myocardial infarction
  77. The contribution of major risk factors and job strain to occupational class differences in coronary heart disease incidence: the MONICA Brianza and PAMELA population-based cohorts
  78. Gender differences in the association between education and the incidence of cardiovascular events in Northern Italy
  79. Social status and cardiovascular disease: a Mediterranean case. Results from the Italian Progetto CUORE cohort study
  80. Design and evaluation of a semantic approach for the homogeneous identification of events in eight patient databases: a contribution to the European EU-ADR project
  81. Persistence with oral and transdermal hormone replacement therapy and hospitalisation for cardiovascular outcomes
  82. American Society of Transplantation Executive Summary on Pediatric Lung Transplantation
  83. Role of Transbronchial Biopsies in Pediatric Lung Diseases
  84. Analysis of Early Deaths After Isolated Lung Transplantation
  85. Cytokine mRNA profiles in Epstein–Barr virus‐associated post‐transplant lymphoproliferative disorders